美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

The Nightview Fund

34.48

+0.65651.94%

成交量：712.00

成交额：2.46万

市值：3,047.24万

市盈率：- -

高：34.48

开：34.48

低：34.48

收：33.82

52周最高：38.42

52周最低：22.38

股本：88.38万

流通股本：88.38万

量比：3.94

换手率：0.08%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

The Nightview Fund

交易所：

ARCA

成立时间：

2018

员工人数：

- -

公司地址：

10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States

官网：

http://www.nightstartx.com

邮编：

73120

电话：

传真：

405-896-5825

简介：

Nightstar Therapeutics Plc最初于2013年5月根据英格兰和威尔士的法律成立，随后于2014年1月更名为NightstaRx Limited。该公司是一家领先的临床阶段基因治疗公司，专注于开发和治疗药物患有罕见的遗传性视网膜疾病，否则会进入失明。利用他们在眼科，基因治疗和药物开发方面的专业知识，他们正在开发一系列专有产品候选人，旨在大幅度修改或停止目前尚未批准的治疗的遗传性视网膜疾病的进展。他们的任务是维护和通过构建领先的垂直整合视网膜基因治疗公司，恢复患者的视力。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NITE/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NITE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","market":"US","secType":"STK","nameCN":"The Nightview Fund","latestPrice":34.4801,"timestamp":1774277398240,"preClose":33.8236,"halted":0,"volume":712,"delay":0,"changeRate":0.019409524710557163,"floatShares":883768,"shares":883768,"eps":0,"marketStatus":"交易中","change":0.6565,"latestTime":"03-23 10:52:55 EDT","open":34.4801,"high":34.4801,"low":34.4801,"amount":24554.333176,"amplitude":0,"askPrice":34.62,"askSize":1800,"bidPrice":34.53,"bidSize":1800,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":1506571200000,"exchange":"ARCA","adjPreClose":33.8236,"sharesOutstanding":943768,"nav":33.82,"aum":29887643.73,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.84,"preClose":33.8236,"latestTime":"16:04 EDT","volume":1,"amount":33.8236,"timestamp":1774037062187,"change":0.0164,"changeRate":0.000485,"amplitude":0},"volumeRatio":3.935932},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","floatShares":883768,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.935932,"shares":883768,"dividePrice":0,"high":34.4801,"amplitude":0,"preClose":33.8236,"low":34.4801,"week52Low":22.38,"pbRate":"--","week52High":38.42,"institutionHeld":0,"latestPrice":34.4801,"eps":0,"divideRate":0,"volume":712,"delay":0,"ttmEps":0,"open":34.4801,"prevYearClose":36.612,"prevWeekClose":33.8236,"prevMonthClose":35.9065,"prevQuarterClose":36.612,"fiveDayClose":34.7071,"twentyDayClose":34.5091,"sixtyDayClose":37.3737},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NITE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NITE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1858671235,"yearFounded":2018,"address":"10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States","zipCode":"73120","officePhone":"405-778-8377","officeFax":"405-896-5825"},"stockCompanyDetail":{"websiteUrl":"http://www.nightstartx.com","stockEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.0878},{"period":"6month","weight":-0.0443},{"period":"1year","weight":0.273},{"period":"ytd","weight":-0.0762}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nightstar Therapeutics Plc最初于2013年5月根据英格兰和威尔士的法律成立，随后于2014年1月更名为NightstaRx Limited。该公司是一家领先的临床阶段基因治疗公司，专注于开发和治疗药物患有罕见的遗传性视网膜疾病，否则会进入失明。利用他们在眼科，基因治疗和药物开发方面的专业知识，他们正在开发一系列专有产品候选人，旨在大幅度修改或停止目前尚未批准的治疗的遗传性视网膜疾病的进展。他们的任务是维护和通过构建领先的垂直整合视网膜基因治疗公司，恢复患者的视力。","exchange":"ARCA","name":"The Nightview Fund","nameEN":"The Nightview Fund"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":null}}